- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 8.31M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $537K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.28M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $4.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $11M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $46.17M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $45.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $46.67M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $62.87M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $64.72M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $73.09M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $82.3M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $87.68M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $98.33M |
| Operating Cash Flow | Q1 2025 · Dec 31, 2024 | −$48.8M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$14.59M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 6.11M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $30K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $67.81M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $45.2M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.80 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.80 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $8.96M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $3.07M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.24M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.79M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $10.37M |